Clinical and pathological predictors of engraftment for patient-derived xenografts in lung adenocarcinoma.

Saved in:
Bibliographic Details
Title: Clinical and pathological predictors of engraftment for patient-derived xenografts in lung adenocarcinoma.
Authors: Ogawa H; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada; Division of Thoracic Surgery, Graduate School of Medicine, Kobe University, Hyogo, Japan., Koga T; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada., Pham NA; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Bernards N; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada., Gregor A; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada., Sata Y; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada., Kitazawa S; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada., Hiraishi Y; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada., Ishiwata T; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada., Aragaki M; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada., Yokote F; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada., Effat A; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada., Kazlovich K; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada., Li Q; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Hueniken K; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Li M; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Maniwa Y; Division of Thoracic Surgery, Graduate School of Medicine, Kobe University, Hyogo, Japan., Tsao MS; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Electronic address: ming.tsao@uhn.ca., Yasufuku K; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada. Electronic address: kazuhiro.yasufuku@uhn.ca.
Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Aug; Vol. 194, pp. 107863. Date of Electronic Publication: 2024 Jun 28.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-8332
DOI:10.1016/j.lungcan.2024.107863